These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 7571200

  • 1. [Prostaglandin E1 in the diagnosis and therapy of erectile disorders].
    Loran OB, Segal AS, Shcheplev PA.
    Urol Nefrol (Mosk); 1995; (4):35-8. PubMed ID: 7571200
    [Abstract] [Full Text] [Related]

  • 2. The long-term safety of alprostadil (prostaglandin-E1) in patients with erectile dysfunction. The European Alprostadil Study Group.
    Br J Urol; 1998 Oct; 82(4):538-43. PubMed ID: 9806184
    [Abstract] [Full Text] [Related]

  • 3. [Prostaglandin E1 (PGE1) in diagnosis and long-term therapy of erectile dysfunction].
    Derouet H, Weirauch A, Bewermeier H.
    Urologe A; 1996 Jan; 35(1):62-7. PubMed ID: 8851852
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Dose adaptation during training of intracavernous self-injections of prostaglandin E1].
    Staerman F, Veilhan LA, Guiraud P, Coeurdacier P, Cipolla B, Lobel B.
    Prog Urol; 1996 Jan; 6(4):564-8. PubMed ID: 8924934
    [Abstract] [Full Text] [Related]

  • 8. [Intracavernous injection of lipo prostaglandin E1 for the diagnosis of impotence: a comparative study with prostaglandin E1-CD].
    Yajima M, Baba K, Minagawa N, Kohno S, Haraguchi C, Iwamoto T, Osada T.
    Hinyokika Kiyo; 1993 Mar; 39(3):289-92. PubMed ID: 8506803
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. An attempt to standardize the pharmacological diagnostic screening of vasculogenic impotence with prostaglandin E1.
    McMahon CG.
    Int J Impot Res; 1995 Jun; 7(2):83-90. PubMed ID: 7496445
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Prostaglandin E1 with phentolamine for the treatment of erectile dysfunction.
    Meinhardt W, de la Fuente RB, Lycklama à Nijeholt AA, Vermeij P, Zwartendijk J.
    Int J Impot Res; 1996 Mar; 8(1):5-7. PubMed ID: 8735187
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Erectile response to intracavernous injection of linsidomine in 38 impotent patients. Comparison with prostaglandin E1].
    Lemaire A, Buvat J.
    Prog Urol; 1998 Jun; 8(3):388-91. PubMed ID: 9689672
    [Abstract] [Full Text] [Related]

  • 15. [Evaluation of 452 patients with erectile dysfunction treated by combinations of vasoactive agents by penile injection].
    Segenreich E, Israilov S, Shmueli J, Simon D, Baniel J, Livne P.
    Harefuah; 1998 May 01; 134(9):673-8, 750. PubMed ID: 10909609
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Intracavernous injections of prostaglandin E1 in the treatment of erection disorders].
    Beretta G, Zanollo A, Portalupi W.
    Arch Ital Urol Nefrol Androl; 1991 Dec 01; 63(4):481-5. PubMed ID: 1838836
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Initial experiences with prostaglandin E1 and PGE1 prepared injections].
    Mattarelli G, Leibundgut B.
    Helv Chir Acta; 1991 Sep 01; 58(3):335-7. PubMed ID: 1769856
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.